Elsevier's MEDai, a provider of advanced analytic solutions and innovative transformation and advisory services, has announced a new licensing agreement with AmeriBen/IEC Group for MEDai's Risk Navigator Clinical software. The software will assist AmeriBen, a full-service third-party administrator (TPA) that manages more than 150,000 lives, in its population management.
MEDai will provide AmeriBen with Risk Navigator Clinical to analyse and understand the latter's care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for its members.
Risk Navigator Clinical seeks to leverage predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator's results are said to outline areas that provide the greatest potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.
MEDai is projected as a premier provider of advanced analytic solutions and innovative transformation and advisory services for payers, providers, ACOs and other healthcare entities.
